Ji W. Woo

Gyeonggi-do, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Multiple diptericins of the black soldier fly (Hermetia illucens) differentially respond to bacterial challenges.

Multiple diptericins of the black soldier fly (Hermetia illucens) differentially respond to bacterial challenges.

Journal: Journal of invertebrate pathology

Published: August 23, 2024

Alteration of PD-L1 (SP142) status after neoadjuvant chemotherapy and its clinical significance in triple-negative breast cancer.

Alteration of PD-L1 (SP142) status after neoadjuvant chemotherapy and its clinical significance in triple-negative breast cancer.

Journal: Breast cancer research and treatment

Published: December 14, 2023

Alteration of HER2 Status During Breast Cancer Progression: A Clinicopathological Analysis Focusing on HER2-Low Status.

Alteration of HER2 Status During Breast Cancer Progression: A Clinicopathological Analysis Focusing on HER2-Low Status.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: December 03, 2023

PD-L1 (SP142) Expression in Primary and Recurrent/Metastatic Triple-Negative Breast Cancers and Its Clinicopathological Significance.

PD-L1 (SP142) Expression in Primary and Recurrent/Metastatic Triple-Negative Breast Cancers and Its Clinicopathological Significance.

Journal: Cancer research and treatment

Published: September 11, 2023

Correction to: miR-145, miR-205 and miR-451: potential tumor suppressors involved in the progression of in situ to invasive carcinoma of the breast.

Correction to: miR-145, miR-205 and miR-451: potential tumor suppressors involved in the progression of in situ to invasive carcinoma of the breast.

Journal: Breast cancer (Tokyo, Japan)

Published: November 05, 2022

Expression of HLA class I is associated with immune cell infiltration and patient outcome in breast cancer.

Expression of HLA class I is associated with immune cell infiltration and patient outcome in breast cancer.

Journal: Scientific reports

Published: May 03, 2022

miR-145, miR-205 and miR-451: potential tumor suppressors involved in the progression of in situ to invasive carcinoma of the breast.

miR-145, miR-205 and miR-451: potential tumor suppressors involved in the progression of in situ to invasive carcinoma of the breast.

Journal: Breast cancer (Tokyo, Japan)

Published: January 29, 2022

Clinical Application of Next-Generation Sequencing in Patients With Breast Cancer: Real-World Data.

Clinical Application of Next-Generation Sequencing in Patients With Breast Cancer: Real-World Data.

Journal: Journal of breast cancer

Published: December 13, 2021

Role of CXCL10 in the progression of in situ to invasive carcinoma of the breast.

Role of CXCL10 in the progression of in situ to invasive carcinoma of the breast.

Journal: Scientific reports

Published: June 24, 2021

Prognostic implications of regression of metastatic axillary lymph nodes after neoadjuvant chemotherapy in patients with breast cancer.

Prognostic implications of regression of metastatic axillary lymph nodes after neoadjuvant chemotherapy in patients with breast cancer.

Journal: Scientific reports

Published: March 07, 2021

Programmed Death Ligand 1 Immunohistochemistry in Triple-Negative Breast Cancer: Evaluation of Inter-Pathologist Concordance and Inter-Assay Variability.

Programmed Death Ligand 1 Immunohistochemistry in Triple-Negative Breast Cancer: Evaluation of Inter-Pathologist Concordance and Inter-Assay Variability.

Journal: Journal of breast cancer

Published: February 27, 2021

Prognostic significance of S100A8-positive immune cells in relation to other immune cell infiltration in pre-invasive and invasive breast cancers.

Prognostic significance of S100A8-positive immune cells in relation to other immune cell infiltration in pre-invasive and invasive breast cancers.

Journal: Cancer immunology, immunotherapy : CII

Published: July 08, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026